Pharmacokinetic-guided Management of Foslevodopa/Foscarbidopa infusion in PINK1-related Parkinson's disease with neuropsychiatric vulnerability

Clinical Parkinsonism & Related Disorders · Published 2026-01-01 · DOI 10.1016/j.prdoa.2026.100487

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.prdoa.2026.100487

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• An unusual case of Pisa syndrome secondary to anti-IgLon 5 disease · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• One patient, one destiny: A cluster analysis of the Parkinson’s progression Markers Initiative (PPMI) cohort · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• Confirmation of biallelic VPS11 variants as a cause of complex dystonic syndrome · Clinical Parkinsonism & Related Disorders · 2025 · Same journal
• Explore thyself: is it time for metacognition screening in clinical trials? · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• Polysomnographic characteristics in patients with idiopathic dystonia · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• A 3-month music-based recreation program added to stable speech-language therapy in institutionalized patients with Parkinson's disease: a feasibility study · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• Epidemiology of Parkinson’s disease – Global burden of disease research from 1990 to 2021 and future trend predictions · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• Structural covariance network alterations across the spectrum of cognitive status in Parkinson's disease · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• Successful use of continuous subcutaneous Foslevodopa/Foscarbidopa in Parkinson's disease with bipolar disorder without psychiatric destabilization · Clinical Parkinsonism & Related Disorders · 2026 · Same journal
• Cross-cultural adaptation, reliability, and preliminary construct validity of the Japanese version of the Parkinson’s disease pain classification system · Clinical Parkinsonism & Related Disorders · 2026 · Same journal